Clinical trial
Canadian Pharmacogenomics Network for Drug Safety: Genetic Factors Associated With Multiple Sclerosis Treatment
NCT01118130 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Canadian Pharmacogenomics Network for Drug Safety: Genetic Factors Associated With Multiple Sclerosis Treatment
- Lead sponsor
- University of British Columbia
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- May 31, 2025
- Enrollment
- 300 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.